Merck Shares Fall 1.5% as Annual Guidance Misses Expectations—Trump-Driven Drug Price Cuts Weigh
Merck & Co. shares slipped after the pharmaceutical giant issued annual guidance below market expectations, citing Trump-era drug price cuts and patent expirations.
Chong Kun Dang CEO Kim Young-joo warned that further drug price cuts could force South Korea's pharmaceutical industry to abandon domestic manufacturing, citing rising costs and declining profitability, while urging policy reforms to protect innovation and R&D investment.
#YonhapInfomax #ChongKunDang #DrugPriceCuts #DomesticManufacturing #PharmaceuticalIndustry #RDInvestment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=102001
Chong Kun Dang CEO Kim Young-joo Warns Drug Price Cuts Could Force Abandonment of Domestic Manufacturing
Chong Kun Dang CEO Kim Young-joo warned that further drug price cuts could force South Korea's pharmaceutical industry to abandon domestic manufacturing, citing rising costs and declining profitability, while urging policy reforms to protect innovation and R&D investment.
Daewoong Pharmaceutical Vice Chairman Yoon Jae-chun Says 'Lack of Funds Prevents Global Clinical Trials—Industry Cannot Withstand Drug Price Cuts'
Daewoong Pharmaceutical's Vice Chairman warns that South Korea's drugmakers lack funds for global R&D and cannot withstand the government's planned drug price cuts, highlighting industry-wide financial strain.
Chong Kun Dang Reports Q3 Operating Profit of 20.5 Billion Won, Down 18.7% Year-on-Year (Update)
Chong Kun Dang Pharmaceutical posted a 19% drop in Q3 operating profit despite higher sales, as drug price cuts and increased R&D spending weighed on margins.
Celltrion Chairman Seo Jung-jin - 'No Impact from US Drug Price Cuts... It's Rather an Opportunity'
Celltrion Chairman Seo Jung-jin sees US drug price cuts as an opportunity, maintains 5 trillion won sales target, and plans to decide on US factory by year-end.
Yonhap Infomax News
owynabderus at KillBait